More Special Issues

About the Journal

Clinical Medicine Research

(ISSN Online: 2326-9057)

About the Special Issue

A Special Issue of Clinical Medicine Research (ISSN Online 2326-9057)

Deadline for manuscript submissions: Oct. 31, 2022

Paraneoplastic limbic encephalitis is a rare neurological disorder characterized by subacute onset, in day or up to twelve weeks, of seizures, short-term memory loss, confusion and psychiatric symptoms suggesting involvement of the limbic system. In addition to the “well”-defined classical paraneoplastic syndromes with antibodies which target intracellular proteins (e.g., antiHu, anti-Yo, anti-Ri), a new group of antibodies associated with autoimmune encephalitis and their correlating symptoms, have been defined. They interact directly with cell-surface neuronal receptors or synaptic proteins. Unlike in classical paraneoplastic syndromes, in cell-surface or synaptic antibody-syndromes the presence of a tumor is variable, they respond to multimodal immunotherapy and seem to have a better overall prognosis. Autoimmune encephalitis Associated With Antibodies Against Neuronal Cell Surface Antigens includes various forms such as N-methyl D-aspartate receptor (NMDA-R) encephalitis, Anti-AMPA-R (α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor), Glycine receptor (Gly-R), DPPX (dipeptidyl-peptidase-like protein-6), anti-contactin-associated protein-2 (CASPR2), Antibodies against metabotropic glutamate receptor 5 (mGLUR5). Autoimmune encephalitis can manifest with several distinct syndromes, complicating its recognition. The classical presentation of encephalitis consists of a subacute (days to a few weeks) progressive decrease in the level of consciousness, often with fluctuations, and altered cognition. Memory, especially retention of new information, may be impaired early in the clinical course. Patients may progress to coma.
This special issue aims to help clinicians, both neurologists and other specialists, to promptly suspect and treat paraneoplastic limbic encephalitis. We will particularly focus on presentation (typical or peculiar), diagnosis, etiologies, but also treatment of them, expecially the forms associated with Antibodies Against Neuronal Cell Surface Antigens.
Perspective or retrospective studies, case reports, updates, reviews and guidelines proposals will be accepted.


  1. Encephalitis
  2. Limbic
  3. Autoimmune
  4. Paraneoplastic
  5. Symptoms and Signs, Diagnosis and Management of Paraneoplastic Limbic Encephalitis
  6. Treatment, Outcome and Prognosis of Paraneoplastic Limbic Encephalitis
Lead Guest Editor
  • Maria Sofia Cotelli

    Neurology, Asst Valcamonica , Esine, Italy

Guest Editor

A special issue is composed of a lead guest editor and a team of guest editors. Currently, there is no guest editor for this special issue and we sincerely invite the scholars in related fields to join it.

Join Us
Call for Papers

This special issue is open for submissions of original research. It accepts full papers, abstracts and tentative paper titles. The submission deadline is Oct. 31, 2022. Authors are encouraged to contribute research in related fields to the special issue.

Manuscript Submission

Publishing research works with Science Publishing Group is simple and efficient. Here are 3 ways for you to submit your manuscript.

1. Quick Submission

Quick Submission helps authors submit their manuscripts in a simple and quick way.

Special Issue Title*
Paraneoplastic Limbic Encephalitis

Or click here to select another Special Issue that is more appropriate for your manuscript.

Select Another Special Issue
Step 1-Please Select a Category  *
  • Category
Step 2-Please Select a Special Issue  *
Special Issue Title
Article Processing Charge

1. Please select your research category in the left column first.
2. Then select a Special Issue to submit your paper in the right column.

Cancle Confirm
Type of Submission*

The submission can be in the forms of full paper, abstract or the tentative title of a paper.

Upload Full Paper*

1. Allow only .doc, .docx and .tex format.
2. Files should not exceed 20MB.

Paper Title*


Tentative Date for Submitting the Full Paper*

The submission deadline is Oct. 31, 2022.

Paper Title*

Tentative Date for Submitting the Full Paper*

The submission deadline is Oct. 31, 2022.

First Name*

Last Name*

Email Address*

A follow-up email will be sent to the given email address within 3 working days.

2. Email Submission

Manuscripts can also be submitted by the email. Please send your manuscript directly to this email address:

Please type "Paraneoplastic Limbic Encephalitis Manuscript Submission" as the subject of your email.

3. Online Submission

Authors can also log into the Online Submission System to finish the submission: